| . | China (N = 254) . | Japan (N = 250) . | Taiwan (N = 100) . | Overall (N=604) . |
|---|---|---|---|---|
| Sildenafil | ||||
| Very satisfied | 27% | 19% | 14% | 22% |
| Fairly satisfied | 68% | 60% | 69% | 65% |
| Tadalafil | ||||
| Very satisfied | 20% | 23% | 14% | 20% |
| Fairly satisfied | 78% | 57% | 64% | 67% |
| Vardenafil | ||||
| Very satisfied | 20% | 20% | –∗ | 20% |
| Fairly satisfied | 68% | 61% | –∗ | 65% |
| Overall – All ED treatments | ||||
| Very satisfied | 25% | 20% | 16% | 22% |
| Fairly satisfied | 69% | 59% | 59% | 63% |
| . | China (N = 254) . | Japan (N = 250) . | Taiwan (N = 100) . | Overall (N=604) . |
|---|---|---|---|---|
| Sildenafil | ||||
| Very satisfied | 27% | 19% | 14% | 22% |
| Fairly satisfied | 68% | 60% | 69% | 65% |
| Tadalafil | ||||
| Very satisfied | 20% | 23% | 14% | 20% |
| Fairly satisfied | 78% | 57% | 64% | 67% |
| Vardenafil | ||||
| Very satisfied | 20% | 20% | –∗ | 20% |
| Fairly satisfied | 68% | 61% | –∗ | 65% |
| Overall – All ED treatments | ||||
| Very satisfied | 25% | 20% | 16% | 22% |
| Fairly satisfied | 69% | 59% | 59% | 63% |
The number of vardenafil users from Taiwan was small (n = 5); none of these patients provided a response to the question on treatment satisfaction.
| . | China (N = 254) . | Japan (N = 250) . | Taiwan (N = 100) . | Overall (N=604) . |
|---|---|---|---|---|
| Sildenafil | ||||
| Very satisfied | 27% | 19% | 14% | 22% |
| Fairly satisfied | 68% | 60% | 69% | 65% |
| Tadalafil | ||||
| Very satisfied | 20% | 23% | 14% | 20% |
| Fairly satisfied | 78% | 57% | 64% | 67% |
| Vardenafil | ||||
| Very satisfied | 20% | 20% | –∗ | 20% |
| Fairly satisfied | 68% | 61% | –∗ | 65% |
| Overall – All ED treatments | ||||
| Very satisfied | 25% | 20% | 16% | 22% |
| Fairly satisfied | 69% | 59% | 59% | 63% |
| . | China (N = 254) . | Japan (N = 250) . | Taiwan (N = 100) . | Overall (N=604) . |
|---|---|---|---|---|
| Sildenafil | ||||
| Very satisfied | 27% | 19% | 14% | 22% |
| Fairly satisfied | 68% | 60% | 69% | 65% |
| Tadalafil | ||||
| Very satisfied | 20% | 23% | 14% | 20% |
| Fairly satisfied | 78% | 57% | 64% | 67% |
| Vardenafil | ||||
| Very satisfied | 20% | 20% | –∗ | 20% |
| Fairly satisfied | 68% | 61% | –∗ | 65% |
| Overall – All ED treatments | ||||
| Very satisfied | 25% | 20% | 16% | 22% |
| Fairly satisfied | 69% | 59% | 59% | 63% |
The number of vardenafil users from Taiwan was small (n = 5); none of these patients provided a response to the question on treatment satisfaction.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
